These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6481186)

  • 41. Oral Infectivity of Vibrio vulnificus in Suckling Mice.
    Reyes AL; Johnson CH; Spaulding PL; Stelma GN
    J Food Prot; 1987 Dec; 50(12):1013-1016. PubMed ID: 30978826
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Molecular Pathogenesis of Vibrio vulnificus.
    Gulig PA; Bourdage KL; Starks AM
    J Microbiol; 2005 Feb; 43 Spec No():118-31. PubMed ID: 15765065
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [NAG-vibrio serovar 2 causing a generalized infection].
    Miliutin VN; Somova AG; Medinskiĭ GM; Podosinnokova LS; Marchuk LM
    Zh Mikrobiol Epidemiol Immunobiol; 1982 Mar; (3):24-5. PubMed ID: 7080748
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A K+ yptake protein, TrkA, is required for serum, protamine, and polymyxin B resistance in Vibrio vulnificus.
    Chen YC; Chuang YC; Chang CC; Jeang CL; Chang MC
    Infect Immun; 2004 Feb; 72(2):629-36. PubMed ID: 14742502
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Possible virulence factors of Staphylococcus aureus in a mouse septic model.
    Tao M; Yamashita H; Watanabe K; Nagatake T
    FEMS Immunol Med Microbiol; 1999 Feb; 23(2):135-46. PubMed ID: 10076910
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Quantification and comparison of virulence and characteristics of different variants of carbapenemase-producing Klebsiella pneumoniae clinical isolates from Taiwan and the United States.
    Chiang TT; Yang YS; Yeh KM; Chiu SK; Wang NC; Lin TY; Huang LY; Chang FY; Siu LK; Lin JC; Chen JH
    J Microbiol Immunol Infect; 2016 Feb; 49(1):83-90. PubMed ID: 26514941
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Serum bactericidal activity and phagocytosis in host defence against Haemophilus ducreyi.
    Lagergård T; Frisk A; Purvèn M; Nilsson LA
    Microb Pathog; 1995 Jan; 18(1):37-51. PubMed ID: 7783597
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Low-density lipoprotein protects Vibrio vulnificus-induced lethality through blocking lipopolysaccharide action.
    Park KH; Kim JS; Lee YR; Moon YJ; Hur H; Choi YH; Kim CH; Kim UH; Song EK; Yoo WH; Lee CS; Kim BS; Lee SH; Ryu PY; Han MK
    Exp Mol Med; 2007 Oct; 39(5):673-8. PubMed ID: 18059143
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Metalloprotease is not essential for Vibrio vulnificus virulence in mice.
    Shao CP; Hor LI
    Infect Immun; 2000 Jun; 68(6):3569-73. PubMed ID: 10816513
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Serum resistance and hemagglutination ability of marine vibrios pathogenic for fish.
    Trust TJ; Courtice ID; Khouri AG; Crosa JH; Schiewe MH
    Infect Immun; 1981 Dec; 34(3):702-7. PubMed ID: 7333667
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Vibrio vulnificus. A marine bacterium with lethal potential].
    Melhus A; Larsson C; Schliamser S
    Lakartidningen; 2001 Aug; 98(32-33):3400-2. PubMed ID: 11526658
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Influence of iron-chelated growth conditions on outer membrane protein production and virulence of Vibrio tubiashii.
    Jean-Gilles Beaubrun J; Gopinath G; Kothary MH; Franco A; Curtis SK; Eribo BE; Tall BD
    Food Microbiol; 2011 Oct; 28(7):1409-13. PubMed ID: 21839393
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Differing resistance to polymorphonuclear cells of halophilic- and hypotonic-types of Vibrio vulnificus.
    Tsuru S; Taniguchi M; Fujisawa H; Zinnaka Y; Nomoto K
    J Clin Lab Immunol; 1987 Apr; 22(4):185-9. PubMed ID: 3612754
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pulmonary damage by Vibrio vulnificus cytolysin.
    Park JW; Ma SN; Song ES; Song CH; Chae MR; Park BH; Rho RW; Park SD; Kim HR
    Infect Immun; 1996 Jul; 64(7):2873-6. PubMed ID: 8698528
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A silkworm infection model to investigate Vibrio vulnificus virulence genes.
    Yamamoto M; Kashimoto T; Yoshimura Y; Tachibana N; Kuroda S; Miki Y; Kitabayashi S; Tong P; Xiao J; Tanaka K; Hamamoto H; Sekimizu K; Yamamoto K
    Mol Med Rep; 2016 Nov; 14(5):4243-4247. PubMed ID: 27748924
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Vibrio vulnificus damages macrophages during the early phase of infection.
    Tsuchiya T; Mitsuo E; Hayashi N; Hikita Y; Nakao H; Yamamoto S; Miyamoto K; Tsujibo H
    Infect Immun; 2007 Sep; 75(9):4592-6. PubMed ID: 17591793
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Increasing opsonizing and killing effect of serum from patients with recurrent K1 Klebsiella pneumoniae liver abscess.
    Yeh FC; Yeh KM; Siu LK; Fung CP; Yang YS; Lin JC; Chang FY
    J Microbiol Immunol Infect; 2012 Apr; 45(2):141-6. PubMed ID: 22444545
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evidence for the presence of a capsule in Vibrio vulnificus.
    Amako K; Okada K; Miake S
    J Gen Microbiol; 1984 Oct; 130(10):2741-3. PubMed ID: 6512503
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Human serum bactericidal activity against Haemophilus influenzae type b.
    Stull TL; Jacobs RF; Haas JE; Roberts MC; Wilson CB; Smith AL
    J Gen Microbiol; 1984 Mar; 130(3):665-72. PubMed ID: 6374030
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cytolytic activity and virulence of Vibrio damsela.
    Kreger AS
    Infect Immun; 1984 May; 44(2):326-31. PubMed ID: 6715036
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.